Sampath Anand

EVP, Ops & Clinical Research at MASIMO CORP

Sold, on record
$36.6M
Dollars the filings state
Form 4 sales
10
Latest Jan 28, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MASIMO CORPUnusual
    Jul 11, 2017 2017

    Sold 40,000 shares at $92.00 ($3.7M)

    Sampath Anand, Chief Operating Officer

    Sold 80% of holdings ($4.6M position)10,000 shares leftFiling

  2. 2 Form 4 sale MASIMO CORPUnusual
    Nov 28, 2018 +505 days

    Sold 30,000 shares at $110.00 ($3.3M)

    Sampath Anand, Chief Operating Officer

    Sold 72.7% of holdings ($4.5M position)11,272 shares leftFiling

  3. 3 Form 4 sale MASIMO CORPUnusual
    Jan 15, 2019 +48 days

    Sold 30,000 shares at $115.00 ($3.5M)

    Sampath Anand, Chief Operating Officer

    Sold 70.6% of holdings ($4.9M position)12,518 shares leftFiling

  4. 4 Form 4 sale MASIMO CORPUnusual
    Jun 14, 2019 +150 days

    Sold 30,000 shares at $142.39 ($4.3M)

    Sampath Anand, EVP, Ops & Clinical Research

    Sold 70.6% of holdings ($6.1M position)12,518 shares left1x usual sizeFiling

  5. 5 Form 4 sale MASIMO CORPUnusual
    Nov 20, 2019 +159 days

    Sold 15,000 shares at $155.00 ($2.3M)

    Sampath Anand, EVP, Ops & Clinical Research

    Sold 54.5% of holdings ($4.3M position)12,518 shares left0.5x usual sizeFiling

  6. 6 Form 4 sale MASIMO CORPUnusual
    Apr 13, 2020 +145 days

    Sold 19,796 shares at $180.00 ($3.6M)

    Sampath Anand, EVP, Ops & Clinical Research

    Sold 59% of holdings ($6M position)13,782 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale MASIMO CORPUnusual
    Dec 15, 2020 +246 days

    Sold 30,000 shares at $265.60 ($8M)

    Sampath Anand, EVP, Ops & Clinical Research

    Sold 68.5% of holdings ($11.6M position)13,782 shares left1.2x usual sizeFiling

  8. 8 Form 4 sale MASIMO CORPUnusual
    Jan 28, 2026 +1870 days

    Sold 18,680 shares at $136.81 ($2.6M)

    Sampath Anand, EVP, Ops & Clinical Research

    No 10b5-1 planSold 31.3% of holdings ($8.2M position)40,909 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Sampath Anand
Source
Jan 28, 2026Jan 30, 2026MASIMO CORPEVP, Ops & Clinical ResearchForm 4 sale18,680$2.6M31.3%UnusualSEC
Dec 15, 2020Dec 17, 2020MASIMO CORPEVP, Ops & Clinical ResearchForm 4 sale30,000$8M68.5%UnusualSEC
Apr 13, 2020Apr 15, 2020MASIMO CORPEVP, Ops & Clinical ResearchForm 4 sale19,796$3.6M59.0%UnusualSEC
Nov 20, 2019Nov 21, 2019MASIMO CORPEVP, Ops & Clinical ResearchForm 4 sale15,000$2.3M54.5%UnusualSEC
Jun 14, 2019Jun 18, 2019MASIMO CORPEVP, Ops & Clinical ResearchForm 4 sale30,000$4.3M70.6%UnusualSEC
Jan 15, 2019Jan 16, 2019MASIMO CORPChief Operating OfficerForm 4 sale30,000$3.5M70.6%UnusualSEC
Nov 28, 2018Nov 30, 2018MASIMO CORPChief Operating OfficerForm 4 sale30,000$3.3M72.7%UnusualSEC
Jul 11, 2017Jul 13, 2017MASIMO CORPChief Operating OfficerForm 4 sale40,000$3.7M80.0%UnusualSEC
Nov 1, 2016Nov 2, 2016MASIMO CORPChief Operating OfficerForm 4 sale65,000$3.6M100.0%UnusualSEC
Nov 6, 2015Nov 10, 2015MASIMO CORPChief Operating OfficerForm 4 sale45,000$1.9M100.0%UnusualSEC